Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis

Stroke

Volumn 38, Issue 7, 2007, Pages 2055-2062

  Williams, Janice E ^a,c   Chimowitz, Marc I ^a   Cotsonis, George A ^b   Lynn, Michael J ^b   Waddy, Salina P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Cerebrovascular disease; Gender; Intracranial arterial disease; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STROKE; SYMPTOMATOLOGY;

AGED; ANTICOAGULANTS; ASPIRIN; CEREBROVASCULAR ACCIDENT; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIAL DISEASES; KAPLAN-MEIERS ESTIMATE; LIFE STYLE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 34347347219     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.482240     Document Type: Article

References (31)

1. The Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003;22:106-117.
2. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. The Northern Manhattan Stroke Study. Stroke. 1996;27:1974-1980.
3. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke. 1995;26:14-20.
4. Klijn CJM, Kappelle LJ, Algra A, Van Gijn J. Outcome in patients with symptomatic occlusion of the internal carotid artery or intracranial arterial lesions: a meta-analysis of the role of baseline characteristics and type of antithrombotic treatment. Cerebrovasc Dis. 2001;12:228-234.
5. Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke. 2003;34:2361-2366.
6. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648-655.
7. Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions: effects of age, race, and sex. Stroke. 1993;24(Suppl 1):I16-I19.
8. Moossy J. Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke. 1993;24(Suppl 1):I22-I23.
9. Feldman E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, Caplan LR. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990;40:1541-1545.
10. Resch JA, Baker AB. Etiologic mechanisms in cerebral atherosclerosis: preliminary study of 3,839 cases. Arch Neurol. 1964;10:617-628.
11. Flora GC, Baker AB, Loewenson RB, Klassen AC. A comparative study of cerebral atherosclerosis in males and females. Circulation. 1968;38:859-869.
12. Solberg LA, McGarry PA, Moossy J, Tejada C, Løken AC, Robertson WB, Donoso S. Distribution of cerebral atherosclerosis by geographic location, race, and sex. Lab Invest. 1968;18:604-612.
13. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996;27:373-380.
14. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke. The Framingham Study. Stroke. 1982;13:290-295.
15. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
16. Rosengren A, Wilhelmsen L, Orth-Gomér K. Coronary disease in relation to social support and social class in Swedish men. Eur Heart J. 2004;25:56-63.
17. Brummett BH, Barefoot JC, Siegler IC, Clapp-Channing NE, Lytle BL, Bosworth HB, Williams RB, Mark DB. Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. Psychosom Med. 2001;63:267-272.
18. Boden-Albala B, Litwak E Elkind MSV, Rundek T, Sacco RL. Social isolation and outcomes post stroke. Neurology. 2005;64:1888-1892.
19. House JS. Social isolation kills, but how and why? Psychosomatic Med. 2001;63:273-274.
20. Qureshi AI, Suri MFK, Saad M, Hopkins LN. Educational attainment and risk of stroke and myocardial infarction. Med Sci Monit. 2003;9:CR466-473.
21. Kapral MK, Wang H, Mamdani M, Tu JV. Effect of socioeconomic status on treatment and mortality after stroke. Stroke. 2002;33:268-275.
22. Arrich J, Lalouschek W, Mullner M. Influence of socioeconomic status on mortality after stroke: Retrospective cohort study. Stroke. 2005;36:310-314.
23. Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J. Socioeconomic factors, health behaviors and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998;279:1703-1708.
24. Liebeskind DS, Laughton AL, Kim D, Starkman S, Salamon N, Villablanca P, Saver JL. Vessel size explains gender differences in response to intravenous thrombolysis for acute stroke (Abstract). Stroke. 2006;37:622.
25. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ, and for the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
26. Marrugat J, Garcia M, Elosua R, Aldasoro E, Tormo MJ, Zurriaga O, Aros F, Masia R, Sanz G, Valle V, Lopez De Sa E, Sala J, Segura A, Rubert C, Moreno C, Cabades A, Molina L, Lopez-Sendon JL, Gil M. IBERICA Investigators, PRIAMHO Investigators, RESCATE Investigators, PEPA Investigators, REGICOR Investigators. Short-term (28 days) prognosis between genders according to the type of coronary event (Q-wave versus non-Q-wave acute myocardial infarction versus unstable angina pectoris). Am J Cardiol. 2004;94:1161-1165.
27. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM, for the National Registry of Myocardial Infarction 2 Participants. Sex-based differences in early mortality after myocardial infarction. N Engl J Med. 1999;341:217-225.
28. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21:69-75.
29. Sala J, Masiá R, González de Molina F-J, Fernández-Real JM, Gil M, Bosch D, Ricart W, Sentí M, Marrugat J, for the REGICOR Investigators. Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health. 2002;56:707-712.
30. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM, for the National Registry of Myocardial Infarction 2 Participants. Impact of history of diabetes mellitus on hospital mortality in men and women with first acute myocardial infarction patients. Am J Cardiol. 2000;85:1486-1489.
31. Melchior T, Køber L, Madsen CR, Seibaek M, Jensen GVH, Hildebrandt P, Torp-Pedersen C, on behalf of the TRACE Study Group. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. Eur Heart J. 1999;20:973-978.